Low correlation between serum thyroglobulin and 131I radioiodine whole body scintigraphy: implication for postoperative disease surveillance in differentiated thyroid cancer

被引:0
|
作者
Thai, Janice N. [1 ]
De Marchena, Ingrid Rymer [2 ]
Nehru, Vijeyaluxmy Motilal [3 ]
Landau, Elliot [1 ]
Demissie, Seleshi [1 ]
Josemon, Raina [1 ]
Peti, Steven [1 ]
Brenner, Arnold I. [1 ]
机构
[1] Staten Island University Hospital, Northwell Health, Staten Island,NY, United States
[2] Department of Internal Medicine, Presbyterian Kaseman Hospital, Albuquerque,NM, United States
[3] McLeod Oncology and Hematology Associates, Florence,SC, United States
来源
Clinical Imaging | 2022年 / 87卷
关键词
Diseases; -; Biomarkers; Glycoproteins;
D O I
暂无
中图分类号
学科分类号
摘要
Purpose: To evaluate postoperative serum thyroglobulin (Tg) as a reliable tumor marker in low-risk differentiated thyroid cancer (DTC). Methods: Two hundred and three patients met the selection criteria of >18 years old; who had undergone total or near total thyroidectomy; had a postoperative Tg, and had undergone 131I pre ablation whole body scan (PA-WBS). The primary endpoint was the correlation between Tg level and functional remnant thyroid tissues. Outcomes were categorized as concordant and discordant. Concordant results were positive Tg (>1 ng/ml) with positive PA-WBS or negative Tg (30 mU/l on thyroxine withdrawal protocol. Results: One hundred ten patients (54.1%) had discordant results (p 1 ng/ml, and 5 patients had negative PA-WBS and Tg 1 ng/ml and negative PA-WBS. There were 74 patients with high TSH (>30 mU/l) on abstention (thyroxine withdrawal protocol). Twenty-four (32.5%) had discordant results (p © 2022 Elsevier Inc.
引用
收藏
页码:1 / 4
相关论文
共 50 条
  • [21] Low activity treatment with 131I in differentiated thyroid cancer
    Olivan-Sasot, P.
    Prado-Wohlwend, S.
    Sanchez-Vano, R.
    Yepes-Agudelo, A.
    Agudelo-Cifuentes, M.
    Bernal-Vergara, J.
    Bello-Arques, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S608 - S609
  • [23] External validation of a predictive model for post-treatment persistent disease by 131I whole-body scintigraphy in patients with differentiated thyroid cancer
    Nappi, Carmela
    Megna, Rosario
    Zampella, Emilia
    Volpe, Fabio
    Piscopo, Leandra
    Falzarano, Maria
    Vallone, Carlo
    Pace, Leonardo
    Petretta, Mario
    Cuocolo, Alberto
    Klain, Michele
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2025,
  • [24] COMPARISON OF SERUM THYROGLOBULIN, I-131 AND TL-201 SCINTIGRAPHY IN THE POSTOPERATIVE FOLLOW-UP OF DIFFERENTIATED THYROID-CANCER
    VANSORGEVANBOXTEL, RAJ
    VANECKSMIT, BLF
    GOSLINGS, BM
    NUCLEAR MEDICINE COMMUNICATIONS, 1993, 14 (05) : 365 - 372
  • [25] The efficiency of planning of therapeutic 131I activities in the radioiodine therapy of differentiated thyroid cancer
    Sinyuta, B
    Dzhuzha, D
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (08): : 1004 - 1004
  • [26] Serum thyroglobulin (Tg0) at the time of the first ablative radioiodine treatment (RAI) in patients with differentiated cancer thyroid (DTC): prognostic value and follow up with 131I Whole Body Scan (WBS).
    Bertolazzi, L.
    Barbetti, V.
    Di Ciolo, L.
    Cananzi, C.
    Gaffuri, M.
    Agnese, G.
    Motta, C.
    Piccardo, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S351 - S351
  • [27] Postoperative-stimulated serum thyroglobulin measured at the time of 131I ablation is useful for the prediction of disease status in patients with differentiated thyroid carcinoma
    Lee, Ji In
    Chung, Yun Jae
    Cho, Bo Youn
    Chong, SeMin
    Seok, Ju Won
    Park, Sung Jun
    SURGERY, 2013, 153 (06) : 828 - 835
  • [28] MRI Versus 131I Whole-Body Scintigraphy for the Detection of Lymph Node Recurrences in Differentiated Thyroid Carcinoma
    Mihailovic, Jasna
    Prvulovic, Mladen
    Ivkovic, Miodrag
    Markoski, Branko
    Martinov, Dobrivoje
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2010, 195 (05) : 1197 - 1203
  • [29] Postablation 131I scintigraphy with neck and thorax SPECT-CT and stimulated serum thyroglobulin level predict the outcome of patients with differentiated thyroid cancer
    Ciappuccini, Renaud
    Heutte, Natacha
    Trzepla, Geraldine
    Rame, Jean-Pierre
    Vaur, Dominique
    Aide, Nicolas
    Bardet, Stephane
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2011, 164 (06) : 961 - 969
  • [30] Patients treated for differentiated thyroid cancer with negative 131I whole-body scanning and elevated thyroglobulin levels.: A possible course
    Gutierrez Cardo, A. L.
    Rodriguez Rodriguez, J. R.
    Borrego Dorado, I.
    Navarro Gonzalez, E.
    Tirado Hospital, J. L.
    Vazquez Albertino, R.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR, 2007, 26 (03): : 138 - 145